Olanzapine ondansetron dexamethasone regime versus aprepitant palonosetron dexamethasone regime for the prevention of chemotherapy-induced nausea and vomiting: rcc study

Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2018, Vol 10, Issue 4

Abstract

Background: At the outset of olanzapine gaining popularity as a drug for Chemotherapy induced nausea and vomiting(CINV). Study was conducted with the aim to compare to antiemetic regimes Olanzapine, Ondansetron, Dexamethasone (OOD) with Aprepitant, Palonosetron, Dexamethasone (APD) in patients receiving highly emetogenic chemotherapy. Method: A double bind randomized control study was performed to compare the two antiemetic regimes in patients receiving HEC (Cisplatin>70mg/m2 or Doxorubicin>50mg/m2 and Cyclophosphamide>500mg/m2) with complete response (CR) defined as no vomiting and no rescue (till 5 days post chemotherapy) as the primary endpoint. 270 patients initially allotted to the study of which finally 230 were available for evaluation Results: The primary endpoint of CR was 75% for overall period (92% early period and 75% delayed period) for the OOD arm whereas overall was 70% (81% early period and 70% delayed period) for the APD arm where early period is defined as first 24 hours and delayed as day 2 to day 5 .Nausea control as per MD Anderson Symptom Inventory (MDASI) based questionnaire was better in OOD (60%) vs APD (53%) arm. There was no statistically significant difference between the arms (P>0.05).hence OOD was comparable with APD for prevention of CINV Discussion: study points out an significantly cheaper yet effective option in managing CINV which is a major adverse effect of chemotherapy with repercussions in quality of life and adherence to treatment. The cost factor is of greater significance for a developing country like ours.

Authors and Affiliations

Vishnu H Lal, Rajesh Kumar, Beniwal, S. , Akanksha solanki, Trupti Kothari, Murali Paramanandan, Kumar, H.S. , Neeti Sharma and Jhakar, S. L

Keywords

Related Articles

Contemporaneous trends and recent advances in bone augmentation for dental implant placement

The use of dental implants for the rehabilitation of missing teeth has broadened the treatment options for patients and clinicians equally. The use of dental implants has increased dramatically in the past two decades as...

Neuro-endoscopic cysto-ventriculostomy and biopsy with aid of Neuronavigation in patients with intraventricular lesions in the 3rd ventricle and occlusive hydrocephalus in comparison to stereotactic technique: A series of 41 patients and review of the Literature

Introduction: The intracranial lesions in the third ventricle can have a variety of clinical manifestations. Masses related to the anterior recesses or floor of the third ventricle may manifest as dysfunction of the hypo...

Evaluation of anti-CCP for early diagnosis and assessment of disease severity in rheumatoid arthritis patients

Rheumatoid Arthritis is a severe, progressive, systemic inflammatory disease of unknown etiology characterized by chronic and erosive polyarthritis by abnormal growth of synovial tissue or pannus and causes irreversible...

Diagnosis Of Type Iii Dens Invaginatus In Maxillary Canine Using Cone Beam Computed Tomography: A Rare Case Report

Dens invaginatus commonly known as Dens in dente is an invagination of coronary or root surface, bounded by enamel which can simulate appearance of a tooth within a tooth. It commonly affects the maxillary lateral inciso...

Endo-perio lesions: Diagnosis and clinical considerations

The relationship between periodontal and endodontic disease has aroused confusion, queries and controversy. Differential diagnosis has always been difficult for periodontal and endodontic diseases. A symptomatic tooth ma...

Download PDF file
  • EP ID EP403491
  • DOI -
  • Views 121
  • Downloads 0

How To Cite

Vishnu H Lal, Rajesh Kumar, Beniwal, S. , Akanksha solanki, Trupti Kothari, Murali Paramanandan, Kumar, H. S. , Neeti Sharma and Jhakar, S. L (2018). Olanzapine ondansetron dexamethasone regime versus aprepitant palonosetron dexamethasone regime for the prevention of chemotherapy-induced nausea and vomiting: rcc study. INTERNATIONAL JOURNAL OF CURRENT RESEARCH, 10(4), 67746-67748. https://europub.co.uk/articles/-A-403491